Serum Proteomic Profiling Identifies ACSL4 and S100A2 as Novel Biomarkers in Feline Calicivirus Infection
International Journal of Molecular Sciences · 2026
DOI: 10.3390/ijms27021047 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Chunmei Xu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Animal Biosafety Risk Prevention and Control (North) & Key Laboratory of Veterinary Biological Products and Chemical Drugs of MARA,…. Hauptthemen laut MEDLINE: Coenzyme A Ligases, Biomarkers, Proteomics, Cat Diseases. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Agricultural Science and Technology Innovation Program, National Key Research and Development Program of China.
Abstract (Originalsprache)
Feline calicivirus (FCV) is a highly variable RNA virus that infects domestic cats and circulates endemically within feline populations, causing a wide spectrum of clinical manifestations, from asymptomatic infections to severe disease. Genomic analysis of 69 FCV strains revealed a high prevalence of the virus across multiple provinces in China. In vitro infection of CRFK cells with laboratory isolates FCV-BJ616 and FCV-BJDX40 resulted in significant cytotoxic effects. Serum proteomic analysis identified 221 upregulated and 123 downregulated proteins following infection with FCV-BJ616, and 233 upregulated and 165 downregulated proteins following infection with FCV-BJDX40. Among these, 215 proteins exhibited shared differential expression. Functional analyses revealed enriched pathways, including TNF signaling and ferroptosis. Notably, upregulation of Acyl-CoA Synthetase Long-Chain Family Member 4 (ACSL4) was correlated with lung injury, while downregulation of S100 Calcium Binding Protein A2 (S100A2) was associated with poor prognosis in FCV-associated oral disease. The differential expression of ACSL4 and S100A2 was further validated through Western blot analysis. These results suggest that ACSL4 and S100A2 are promising candidate biomarkers for monitoring FCV infection and disease progression, laying a foundation for future diagnostic and prognostic applications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Animal Biosafety Risk Prevention and Control (North) & Key Laboratory of Veterinary Biological Products and Chemical Drugs of MARA, Institute of Animal Science, Chinese Academy of Agricultural Sciences…
- Beijing Center for Animal Disease Prevention and Control, Beijing 102629, China.
ORCID-Profile: Xinming Tang
Förderung
- Agricultural Science and Technology Innovation Program
- National Key Research and Development Program of China
Zitieren
APA
Xu, C., Liu, H., Gu, H., Wu, D., Tang, X., Liang, L., Hou, S., Ding, J., & Liang, R. (2026). Serum Proteomic Profiling Identifies ACSL4 and S100A2 as Novel Biomarkers in Feline Calicivirus Infection. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27021047
Vancouver
Xu C, Liu H, Gu H, Wu D, Tang X, Liang L, et al. Serum Proteomic Profiling Identifies ACSL4 and S100A2 as Novel Biomarkers in Feline Calicivirus Infection. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27021047
BibTeX
@article{Xu2026,
author = {Xu, Chunmei and Liu, Hao and Gu, Haotian and Wu, Di and Tang, Xinming and Liang, Lin and Hou, Shaohua and Ding, Jiabo and Liang, Ruiying},
title = {Serum Proteomic Profiling Identifies ACSL4 and S100A2 as Novel Biomarkers in Feline Calicivirus Infection},
journal = {International Journal of Molecular Sciences},
year = {2026},
doi = {10.3390/ijms27021047}
}
EUVIMED